Transplant News and Research

RSS

World's first double arm transplant

A German farm worker who lost both arms in a farm accident has become the world's first double arm transplant recipient.

30 Jul 2008

New medical procedure for kidney donor surgery

Advanced Surgical Concepts is pleased to announce that surgeons have used its TriPort device to complete a kidney transplant through only a small incision in the donor's bellybutton.

28 Jul 2008

New human tissue bank

The University of Bradford has unveiled a new facility to provide UK biomedical researchers access to a wide range of human tissue and tissue products.

28 Jul 2008

Hey fever! The surprise benefit of allergies

Long-suffering victims of allergies such as asthma and hay fever might enjoy a surprise benefit, according to research led by the University of New South Wales (UNSW).

24 Jul 2008

Statins appear to improve survival in kidney transplant recipients

For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of Nephrology (JASN).

23 Jul 2008

Stem cell chicken and egg debate moves to unlikely arena: the testes

Logic says it has to be the niche. As air and water preceded life, so the niche, that hospitable environment that shelters adult stem cells in many tissues and provides factors necessary to keep them young and vital, must have emerged before its stem cell dependents.

20 Jul 2008

Higher than average success rate reported for children receiving living donor transplants

Ninety-six per cent of children who have received liver transplants from living relations are still alive five years after surgery, according to research published in the July issue of the British Journal of Surgery.

17 Jul 2008

Superbug breakthrough

The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.

17 Jul 2008

Kidney transplants less successful at night

Kidney transplants should be carried out during the day if possible. At least this is the conclusion suggested by a survey just published by urologists and internists at the University of Bonn (Transplantation Proceedings, vol. 40, p. 1341 ff.).

15 Jul 2008

Corneal transplant technique shows promise in children

For infants and children with blinding diseases of the cornea, a sophisticated new corneal transplantation technique offers the hope of improving vision while overcoming the technical difficulty and low success rate of traditional penetrating keratoplasty (PK) in children, according to reports in the current issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).

15 Jul 2008

AHA recognizes quality of URMC cardiac, heart failure, stroke programs

The American Heart Association/American Stroke Association has honored Strong Memorial Hospital of the University of Rochester Medical Center with a Triple Performance Achievement Award for meeting its high standards for coronary artery disease, heart failure and stroke care.

15 Jul 2008

Potential new way to prevent graft-versus-host disease

A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants.

10 Jul 2008

Researchers crack final part of the immune system code

A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.

10 Jul 2008

Retina transplants show promise in patients with retinal degeneration

Preliminary research shows encouraging results with transplantation of retinal cells in patients with blindness caused by retinitis pigmentosa (RP) and age-related macular degeneration (AMD), according to a report in the August issue of American Journal of Ophthalmology.

10 Jul 2008

Femtosecond laser improves corneal transplant outcomes

Faster recovery times and better visual outcomes are among the early results of a corneal transplant pilot study underway at the University of Michigan Kellogg Eye Center.

7 Jul 2008

Discovery of new function for an old enzyme in sialidosis

The lack of a single protein usually thought of as a run-of-the-mill enzyme that helps to recycle molecules in cells causes an incurable and often fatal disease of children, according to St. Jude Children's Research Hospital investigators.

7 Jul 2008

New clinical trial for patients with asbestos-associated lung cancer

The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.

26 Jun 2008

Penn researchers propose major changes to informed consent for transplantation

University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.

26 Jun 2008

Ranbaxy receives tentative approval to manufacture Valganciclovir hydrochloride tablets

Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valganciclovir Hydrochloride Tablets, 450 mg. Total annual market sales for Valganciclovir HCl Tablets were $239 million (IMS - MAT: March 2008).

25 Jun 2008

Harbor House to assist transplant and critical care patients, families

A dream of local heart transplant patients and volunteers is coming true much earlier than expected thanks to a generous gift provided by a local nonprofit organization.

25 Jun 2008